Technology | Stent Grafts | March 04, 2016

Gore Launches 7.5 cm Gore Viabahn Endoprosthesis with Heparin Bioactive Surface

New device size comes in response to physicians’ requests for additional offerings to expand treatment options

Gore, Viabahn Endoprosthesis with heparin bioactive surface, new 7.5 cm length

March 4, 2016 — W. L. Gore & Associates (Gore) announced the availability of a new 7.5 cm length of the Gore Viabahn Endoprosthesis with heparin bioactive surface. Gore developed this size in response to physician needs for certain clinical situations. The device is now available in six lengths: 2.5, 5, 7.5, 10, 15 and 25 cm.

In 2013, the U.S. Food and Drug Administration (FDA) granted indication for the Gore Viabahn Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts. The flexibility of the device allows placement across the elbow and other challenging venous anastomotic locations.

“Selecting the right length device is an important part of getting good outcomes for dialysis access patients. Until now, some cases required choosing between stacking two devices or unnecessarily covering healthy tissue,” said John Ross, M.D., Dialysis Access Institute, Orangeburg Regional Medical Center, Orangeburg, S.C. “The new 7.5 cm length Viabahn improves the ability to land the device with the most accuracy."

For more information: www.goremedical.com


Additional Content

News | Endovascular Aortic Repair

Sept. 8, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Microbot Medical's Liberty ...

Home September 18, 2025
Home
News | Endovascular Aortic Repair

Sept. 9, 2025 — The John Ritter Foundation for Aortic Health, a nonprofit dedicated to raising awareness, advancing ...

Home September 10, 2025
Home
News | Endovascular Aortic Repair

June 19, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home June 19, 2024
Home
News | Endovascular Aortic Repair

October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research ...

Home October 30, 2023
Home
News | Endovascular Aortic Repair

December 5, 2022 — Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the ...

Home December 05, 2022
Home
Subscribe Now